Who owns KEZAR LIFE SCIENCES INC?
- Ticker: KZR
- CUSIP Number: 49372l209
Tip: Access positions for across all investors
Analyze quarterly positions in Kezar Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kezar Life Sciences stock
Who bought or sold KEZAR LIFE SCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 721k | $5.3M | 0% | Mar 2026 |
|
| Suvretta Capital Management | 717k | $5.3M | 0% | Mar 2026 |
|
| Tang Capital Management | 664k | $4.9M | 0% | Mar 2026 |
|
| Vanguard Group | 341k | $2.1M | 27% | Dec 2025 |
|
| Vanguard Capital Management | 291k | $2.2M | 100% | Mar 2026 |
|
| Rangeley Capital | 243k | $1.8M | 183% | Mar 2026 |
|
| Affinity Asset Advisors | 229k | $1.4M | 100% | Dec 2025 |
|
| Stonepine Capital Management | 156k | $982k | -59% | Dec 2025 |
|
| Acadian Asset Management | 152k | $1.1M | 21% | Mar 2026 |
|
| Millennium Management | 142k | $1.1M | 100% | Mar 2026 |
|
| Renaissance Technologies | 131k | $826k | 13% | Dec 2025 |
|
| Peapod Lane Capital | 127k | $925k | 0% | Mar 2026 |
|
| Susquehanna International | 119k | $747k | 100% | Dec 2025 |
|
| Ikarian Capital | 102k | $758k | 0% | Mar 2026 |
|
| BlackRock | 100k | $742k | 1% | Mar 2026 |
|
| ADAR1 Capital Management | 82k | $608k | -30% | Mar 2026 |
|
| Groupe la Francaise | 80k | $597k | 100% | Mar 2026 |
|
| Aldebaran Capital | 80k | $596k | 0% | Mar 2026 |
|
| Citadel Advisors | 75k | $558k | 100% | Mar 2026 |
|
| Geode Capital Management | 61k | $453k | -11% | Mar 2026 |
|
| Equitec Proprietary Markets | 58k | $427k | 100% | Mar 2026 |
|
| Credit Industriel Et Commercial | 54k | $398k | 100% | Mar 2026 |
|
| Springbok Capital Management | 53k | $333k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 52k | $325k | 26% | Dec 2025 |
|
| Torno Capital | 49k | $360k | 142% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 41k | $306k | 100% | Mar 2026 |
|
| Dimensional Fund Advisors | 30k | $225k | 14% | Mar 2026 |
|
| Rbf Capital | 28k | $209k | 0% | Mar 2026 |
|
| State Street Corporation | 27k | $170k | 28% | Dec 2025 |
|
| Nano Cap New Millennium Growth Fund | 25k | $157k | 100% | Dec 2025 |
|
| Yakira Capital Management | 24k | $178k | 100% | Mar 2026 |
|
| Vazirani Asset Management | 22k | $163k | -55% | Mar 2026 |
|
| Jane Street | 21k | $159k | 100% | Mar 2026 |
|
| Boothbay Fund Management | 16k | $120k | 0% | Mar 2026 |
|
| Northern Trust | 14k | $87k | -1% | Dec 2025 |
|
| Wells Fargo & Company | 5.8k | $43k | -1% | Mar 2026 |
|
| Morgan Stanley | 4.3k | $32k | -25% | Mar 2026 |
|
| Goss Wealth Management | 2.2k | $16k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 1.7k | $13k | 100% | Mar 2026 |
|
| Global Retirement Partners | 1.0k | $6.3k | 0% | Dec 2025 |
|
| Tower Research Capital | 564.00 | $3.5k | -52% | Dec 2025 |
|
| Royal Bank of Canada | 322.00 | $2.0k | 100% | Mar 2026 |
|
| Caitong International Asset Management | 308.00 | $2.3k | 100% | Mar 2026 |
|
| FMR | 208.00 | $1.3k | -98% | Dec 2025 |
|
| Atlantic Trust | 100.00 | $629.000000 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 94.00 | $590.996800 | 4% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 89.00 | $659.997300 | 0% | Mar 2026 |
|
| Hanson McClain Advisors | 50.00 | $315.000000 | 100% | Dec 2025 |
|
| UBS Group | 13.00 | $95.999800 | -68% | Mar 2026 |
|
| Barclays | 1.00 | $6.000000 | 0% | Dec 2025 |
|
Who sold out of Kezar Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Nantahala Capital Management | Dec 2025 | 277k | $1.7M |
| FNY Investment Advisers | Dec 2025 | 50k | $314k |
| None | Dec 2025 | 34k | $212k |
| Bluefin Capital Management | Sep 2025 | 34k | $131k |
| Two Sigma Investments | Dec 2025 | 11k | $71k |
| Jpmorgan Chase & Co | Sep 2025 | 209.00 | $814.995500 |